The United States IVD market overall

• The United States IVD Market was $12 Billion in 2002
• IVD Market is expected to grow to $16 Billion in 2007
• The top use of In Vitro Diagnostics is diabetes testing
• Cancer testing ranks as having the fastest sales growth
• Nucleic Acid Products have one of the fastest growth opportunities

Our Regional Strengths in In Vitro Diagnostics

• According to a 2001 Batelle report, the Southwestern Pennsylvania Region has a highly developed infrastructure for diagnostics.
• Medical labs are the 3rd largest life sciences sub-sector in our region.
• Labs comprise 18+% of non-hospital workers within the life sciences sector.
• According to a 2004 American Association of Medical Colleges report, Pennsylvania is #2 in Academic Medical Center Activity, with $26 Billion in 2002.

In Vitro Diagnostics

“In Vitro” is literally translated as “in glass”. In vitro diagnostics are clinical lab tests conducted on patients to more effectively:

• Diagnose, stage, stratify and treat illness
• Manage chronic illnesses
• Select the most appropriate treatment

Some of the recent major advances in In Vitro Diagnostics include:

• Genetic testing
• Cell surface markers for cancers
• Pharmacogenomics (How cells respond to drugs)
• Molecular-level tests

Our client member companies are innovators in these and many other aspects of In Vitro Diagnostics.